08 Oct Evia Bio

Posted at 18:01h in by Brittany Miller

Allison Hubel, Ph.D., Chief Scientific Officer

Oct. 11 | 3:45pm | Rentschler ATMP Ballroom

Minneapolis, MN

(Private)

Evia Bio delivers better and safer therapeutics enabled by all-natural cryopreservation. Our DMSO-free solutions improve post-thaw performance while reducing manufacturing complexities and patient risk. Evia Bio was founded by leading cryobiologist Allison Hubel, PhD. We are actively partnering with cell therapy leaders to remove DMSO and improve therapeutic efficacy.

www.eviabio.com

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 7-9, 2024
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions